Oncology
Gefitinib Geftinat 250mg Tablet
Non-Small Cell Lung Cancer
Prescription onlyTabletAvailable for export
| Product | Gefitinib Geftinat 250mg Tablet |
|---|---|
| Used for | Non-Small Cell Lung Cancer |
| Dosage form | Tablet |
| Pack | Standard manufacturer pack |
| Manufacturer | Natco Pharma Ltd |
| Composition | Gefitinib (250mg) |
| Pack size | 30 Tablets |
| Storage | Store below 30°C, away from light and moisture. |
| Country of origin | India |
Quantityboxes
No payment is taken on this site. We reply with price, batch, expiry and shipping cost. Ask about this product on WhatsApp
Original packsSealed, labelled
Batch documentsInvoice and COA
Tracked shippingDoor delivery
Gefitinib Geftinat 250mg Tablet is a tablet in our Oncology range, used for non-small cell lung cancer.
Gefitinib Tablet is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.
Hormonal therapy, kinase inhibitors and CDK4/6 inhibitors for breast, prostate, lung, kidney and brain cancers.
This is a prescription medicine and must be used under the supervision of a registered medical practitioner.
